FHB Q1 2026 Earnings EPS Beats Estimates by 178 SPOK Q1 2026 Earnings EPS Misses Estimates by 51 Revenue Data Unavailable Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 CALX Q1 2026 Earnings EPS Matches Estimates Amid Broadband Platform Momentum MOMO Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Movement WHD Q1 2026 Earnings EPS Beats Estimates by 861 Stock Edges Higher